502 Cyclosporine vs. IV corticosteroids for the management of SJS/TEN
Publication
, Conference
Shah, R; Kroshinsky, D
Published in: Journal of Investigative Dermatology
May 2018
Duke Scholars
Published In
Journal of Investigative Dermatology
DOI
ISSN
0022-202X
Publication Date
May 2018
Volume
138
Issue
5
Start / End Page
S85 / S85
Publisher
Elsevier BV
Related Subject Headings
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Shah, R., & Kroshinsky, D. (2018). 502 Cyclosporine vs. IV corticosteroids for the management of SJS/TEN. In Journal of Investigative Dermatology (Vol. 138, pp. S85–S85). Elsevier BV. https://doi.org/10.1016/j.jid.2018.03.509
Shah, R., and D. Kroshinsky. “502 Cyclosporine vs. IV corticosteroids for the management of SJS/TEN.” In Journal of Investigative Dermatology, 138:S85–S85. Elsevier BV, 2018. https://doi.org/10.1016/j.jid.2018.03.509.
Shah R, Kroshinsky D. 502 Cyclosporine vs. IV corticosteroids for the management of SJS/TEN. In: Journal of Investigative Dermatology. Elsevier BV; 2018. p. S85–S85.
Shah, R., and D. Kroshinsky. “502 Cyclosporine vs. IV corticosteroids for the management of SJS/TEN.” Journal of Investigative Dermatology, vol. 138, no. 5, Elsevier BV, 2018, pp. S85–S85. Crossref, doi:10.1016/j.jid.2018.03.509.
Shah R, Kroshinsky D. 502 Cyclosporine vs. IV corticosteroids for the management of SJS/TEN. Journal of Investigative Dermatology. Elsevier BV; 2018. p. S85–S85.
Published In
Journal of Investigative Dermatology
DOI
ISSN
0022-202X
Publication Date
May 2018
Volume
138
Issue
5
Start / End Page
S85 / S85
Publisher
Elsevier BV
Related Subject Headings
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences